Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Witzke

Showing results (1-10 of 311) with videos related to

Pageof 32
Sort By:
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 1, 2022
[Clinical experience using cefiderocol]Oliver Witzke, Thorsten Brenner
Der Nephrologe|February 8, 2021
[Thrombotic microangiopathy]Anja Gäckler, Oliver Witzke
Infection|February 3, 2017
Bibles as a possible source of pathogens in hospitals? A pilot observationBirgit Ross, Oliver Witzke
Der Nephrologe|February 23, 2021
[Acute kidney injury]Thorsten Feldkamp, Oliver Witzke
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
Medizinische Klinik (Munich, Germany : 1983)|April 2, 2009
[Nephrogenic systemic fibrosis]Stefan Becker, Oliver Witzke, Andreas Kribben
Autoimmunity Reviews|December 21, 2018
Th17 cells in renal inflammation and autoimmunitySebastian Dolff, Oliver Witzke, Benjamin Wilde
Rheumatology (Oxford, England)|July 23, 2019
Th17 cells: do regulatory B-cells (Breg) take control in ANCA-vasculitis?Sebastian Dolff, Oliver Witzke, Benjamin Wilde
Kidney & Blood Pressure Research|November 13, 2009
T-lymphocytes and disease mechanisms in Wegener's granulomatosisFan Hua, Benjamin Wilde, Sebastian Dolff, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 13, 2009
Isoagglutinin titre adsorption: breaking the barrier in major AB0-incompatible organ transplantationBenjamin Wilde, Frank Pietruck, Andreas Kribben, et al.
Pageof 32

Showing results (1-10 of 311) with videos related to

Sort By:
Pageof 32
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|August 1, 2022
[Clinical experience using cefiderocol]Oliver Witzke, Thorsten Brenner
Der Nephrologe|February 8, 2021
[Thrombotic microangiopathy]Anja Gäckler, Oliver Witzke
Infection|February 3, 2017
Bibles as a possible source of pathogens in hospitals? A pilot observationBirgit Ross, Oliver Witzke
Der Nephrologe|February 23, 2021
[Acute kidney injury]Thorsten Feldkamp, Oliver Witzke
Transplantation Reviews (Orlando, Fla.)|November 26, 2015
Everolimus immunosuppression in kidney transplantation: What is the optimal strategy?Oliver Witzke, Claudia Sommerer, Wolfgang Arns
Medizinische Klinik (Munich, Germany : 1983)|April 2, 2009
[Nephrogenic systemic fibrosis]Stefan Becker, Oliver Witzke, Andreas Kribben
Autoimmunity Reviews|December 21, 2018
Th17 cells in renal inflammation and autoimmunitySebastian Dolff, Oliver Witzke, Benjamin Wilde
Rheumatology (Oxford, England)|July 23, 2019
Th17 cells: do regulatory B-cells (Breg) take control in ANCA-vasculitis?Sebastian Dolff, Oliver Witzke, Benjamin Wilde
Kidney & Blood Pressure Research|November 13, 2009
T-lymphocytes and disease mechanisms in Wegener's granulomatosisFan Hua, Benjamin Wilde, Sebastian Dolff, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 13, 2009
Isoagglutinin titre adsorption: breaking the barrier in major AB0-incompatible organ transplantationBenjamin Wilde, Frank Pietruck, Andreas Kribben, et al.
Pageof 32